11.82
price up icon1.55%   0.18
after-market Handel nachbörslich: 11.97 0.15 +1.27%
loading

Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten

pulisher
Oct 12, 2025

Statistical indicators supporting Phathom Pharmaceuticals Inc.’s strength2025 Price Targets & Free Long-Term Investment Growth Plans - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Up 6.8%Still a Buy? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Will Phathom Pharmaceuticals Inc. continue its uptrendDay Trade & AI Powered Market Trend Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Phathom Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Short Interest & Long-Term Growth Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Leading vs lagging indicators on Phathom Pharmaceuticals Inc. performanceMarket Performance Report & Long-Term Capital Growth Strategies - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why hedge funds are buying Phathom Pharmaceuticals Inc. stockJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Phathom Pharmaceuticals Hits Day Low of $10.33 Amid Price Pressure - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

When Will Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Breakeven? - simplywall.st

Oct 08, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial officer By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 7.8%Here's What Happened - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer - citybiz

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals, Inc. Appoints Sanjeev Narula as Chief Financial and Business Officer - MarketScreener

Oct 06, 2025
pulisher
Oct 06, 2025

When is the best time to exit Phathom Pharmaceuticals Inc.Global Markets & Expert Approved Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial officer - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals Appoints New Chief Financial Officer - TipRanks

Oct 06, 2025
pulisher
Oct 06, 2025

Phathom Pharmaceuticals appoints Sanjeev Narula as chief financial and business officer - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using Bollinger Bands to evaluate Phathom Pharmaceuticals Inc.2025 Technical Overview & Stock Portfolio Risk Management - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Analyzing recovery setups for Phathom Pharmaceuticals Inc. investorsSwing Trade & Long-Term Safe Investment Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Phathom Pharmaceuticals Inc. see short term momentumQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Tools to monitor Phathom Pharmaceuticals Inc. recovery probabilityJuly 2025 Summary & Safe Capital Preservation Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to integrate Phathom Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How Phathom Pharmaceuticals Inc. stock reacts to Fed rate cutsQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What Fibonacci levels say about Phathom Pharmaceuticals Inc. reboundMarket Risk Report & Daily Stock Momentum Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to build a custom watchlist for Phathom Pharmaceuticals Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 20:30:06 - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Phathom Pharmaceuticals Experiences Evaluation Revision Amid Mixed Performance Indicators - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 09:34:59 - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Trading Up 5.5%Still a Buy? - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 02:22:28 - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Phathom Pharmaceuticals Inc Stock Analysis and ForecastValue Stock Picks & Affordable Trading Growth - earlytimes.in

Sep 29, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):